CorVel (CRVL) Competitors $102.11 -0.39 (-0.38%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$102.10 0.00 (0.00%) As of 06/20/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRVL vs. LH, DGX, DVA, CHE, AMED, MD, AMN, CCRN, RYAN, and ERIEShould you be buying CorVel stock or one of its competitors? The main competitors of CorVel include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Ryan Specialty (RYAN), and Erie Indemnity (ERIE). CorVel vs. Its Competitors Laboratory Co. of America Quest Diagnostics DaVita Chemed Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Ryan Specialty Erie Indemnity Labcorp (NYSE:LH) and CorVel (NASDAQ:CRVL) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their community ranking, dividends, profitability, media sentiment, institutional ownership, risk, analyst recommendations, earnings and valuation. Does the media prefer LH or CRVL? In the previous week, Labcorp had 12 more articles in the media than CorVel. MarketBeat recorded 15 mentions for Labcorp and 3 mentions for CorVel. CorVel's average media sentiment score of 1.83 beat Labcorp's score of 0.97 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Labcorp 8 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has preferable valuation and earnings, LH or CRVL? Labcorp has higher revenue and earnings than CorVel. Labcorp is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLabcorp$13.01B1.69$746M$8.6530.29CorVel$895.59M5.85$95.17M$1.8455.49 Is LH or CRVL more profitable? CorVel has a net margin of 10.63% compared to Labcorp's net margin of 5.55%. CorVel's return on equity of 32.55% beat Labcorp's return on equity.Company Net Margins Return on Equity Return on Assets Labcorp5.55% 15.27% 6.97% CorVel 10.63%32.55%18.22% Which has more volatility & risk, LH or CRVL? Labcorp has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500. Comparatively, CorVel has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Do institutionals & insiders hold more shares of LH or CRVL? 95.9% of Labcorp shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 0.8% of Labcorp shares are owned by company insiders. Comparatively, 47.6% of CorVel shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts prefer LH or CRVL? Labcorp currently has a consensus price target of $274.00, indicating a potential upside of 4.57%. Given Labcorp's stronger consensus rating and higher probable upside, research analysts plainly believe Labcorp is more favorable than CorVel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Labcorp 0 Sell rating(s) 3 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.86CorVel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in LH or CRVL? Labcorp received 433 more outperform votes than CorVel when rated by MarketBeat users. Likewise, 63.92% of users gave Labcorp an outperform vote while only 63.84% of users gave CorVel an outperform vote. CompanyUnderperformOutperformLabcorpOutperform Votes62963.92% Underperform Votes35536.08% CorVelOutperform Votes19663.84% Underperform Votes11136.16% SummaryLabcorp beats CorVel on 11 of the 19 factors compared between the two stocks. Get CorVel News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRVL vs. The Competition Export to ExcelMetricCorVelBUSINESS SVCS IndustryBusiness SectorNASDAQ ExchangeMarket Cap$5.26B$6.07B$13.00B$8.59BDividend YieldN/A2.97%2.61%4.20%P/E Ratio55.6021.5327.2419.15Price / Sales5.851.8450.55101.14Price / Cash42.2213.7424.3655.99Price / Book16.295.015.915.79Net Income$95.17M$150.49M$189.65M$248.80M7 Day Performance-2.82%0.33%2.72%2.13%1 Month Performance-9.07%-1.78%1.84%4.31%1 Year Performance25.21%56.29%28.70%15.77% CorVel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVLCorVel0.9844 of 5 stars$102.11-0.4%N/A+25.1%$5.26B$895.59M55.605,075Positive NewsLHLaboratory Co. of America4.4232 of 5 stars$255.74+0.7%$272.92+6.7%+26.4%$21.41B$13.18B29.0075,500DGXQuest Diagnostics4.8735 of 5 stars$175.90+0.9%$185.73+5.6%+29.7%$19.64B$10.16B22.8749,000Positive NewsDVADaVita4.3706 of 5 stars$137.76-0.1%$164.50+19.4%-2.6%$10.40B$12.97B12.8370,000Positive NewsCHEChemed4.682 of 5 stars$549.14-2.4%$674.00+22.7%+2.6%$8.03B$2.49B27.7514,200News CoveragePositive NewsShort Interest ↑AMEDAmedisys3.2909 of 5 stars$94.22+0.4%$100.75+6.9%+6.4%$3.09B$2.37B37.3920,000Positive NewsMDPediatrix Medical Group2.559 of 5 stars$14.13+0.3%$16.67+17.9%+71.4%$1.21B$1.98B-11.787,850Short Interest ↑AMNAMN Healthcare Services4.3307 of 5 stars$21.36+1.2%$32.08+50.2%-58.7%$817.84M$2.85B-5.554,230Positive NewsCCRNCross Country Healthcare3.5001 of 5 stars$13.10+1.5%$17.93+36.9%-2.5%$429.46M$1.26B-261.952,700News CoverageAnalyst ForecastAnalyst RevisionRYANRyan Specialty3.8886 of 5 stars$66.34-3.2%$75.58+13.9%+21.7%$17.41B$2.65B96.153,850Insider TradeERIEErie Indemnity1.5045 of 5 stars$361.69-2.7%N/A-0.4%$16.71B$3.99B33.836,040News Coverage Related Companies and Tools Related Companies LH Alternatives DGX Alternatives DVA Alternatives CHE Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives RYAN Alternatives ERIE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRVL) was last updated on 6/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorVel Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorVel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
